Total Payments
$221,102
2024 Payments
$8,264
Companies
34
Transactions
1,310
Medicare Patients
29,329
Medicare Billing
$2.7M
Payment Breakdown by Category
Other$121,600 (55.0%)
Travel$74,586 (33.7%)
Food & Beverage$23,410 (10.6%)
Consulting$1,500 (0.7%)
Education$5.90 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $120,600 | 15 | 54.5% |
| Travel and Lodging | $74,586 | 47 | 33.7% |
| Food and Beverage | $23,410 | 1,243 | 10.6% |
| Consulting Fee | $1,500 | 2 | 0.7% |
| Honoraria | $1,000 | 2 | 0.5% |
| Education | $5.90 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $186,352 | 203 | $0 (2020) |
| Boston Scientific Corporation | $12,433 | 141 | $0 (2024) |
| Medtronic, Inc. | $6,287 | 99 | $0 (2024) |
| Biosense Webster, Inc. | $6,141 | 270 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,688 | 185 | $0 (2024) |
| Abbott Laboratories | $1,553 | 106 | $0 (2024) |
| PFIZER INC. | $1,076 | 104 | $0 (2023) |
| AltaThera Pharmaceuticals LLC | $1,022 | 3 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $530.24 | 42 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $525.00 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,264 | 130 | Boston Scientific Corporation ($5,684) |
| 2023 | $4,761 | 152 | Boston Scientific Corporation ($1,509) |
| 2022 | $2,572 | 163 | Biosense Webster, Inc. ($867.58) |
| 2021 | $6,228 | 157 | Medtronic, Inc. ($3,000) |
| 2020 | $7,634 | 106 | Medtronic Vascular, Inc. ($5,075) |
| 2019 | $100,422 | 180 | Medtronic Vascular, Inc. ($97,487) |
| 2018 | $47,463 | 197 | Medtronic Vascular, Inc. ($44,909) |
| 2017 | $43,758 | 225 | Medtronic Vascular, Inc. ($38,882) |
All Payment Transactions
1,310 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Medtronic, Inc. | AURORA EV-ICD MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Implant Cardio Defib - ICDs | ||||||
| 12/12/2024 | Boston Scientific Corporation | INGEVITY+ (Device) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Ingevity+_CRM | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $7.61 | General |
| 11/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $28.74 | General |
| 11/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $19.98 | General |
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $28.02 | General |
| 11/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: DEVICES | ||||||
| 11/05/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Boston Scientific Corporation | INGEVITY+ (Device) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Ingevity+_CRM | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.40 | General |
| Category: Cardiovascular | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $5.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $25.52 | General |
| 10/11/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $5.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $5.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $5.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Boston Scientific Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,750.00 | General |
| Category: General - EP_EP | ||||||
| 09/25/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $5.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 56 | 6,449 | 9,366 | $2.5M | $614,369 |
| 2022 | 59 | 7,005 | 10,862 | $2.5M | $623,085 |
| 2021 | 62 | 8,245 | 12,889 | $2.9M | $775,366 |
| 2020 | 61 | 7,630 | 12,180 | $2.6M | $683,382 |
Total Patients
29,329
Total Services
45,297
Medicare Billing
$2.7M
Procedure Codes
238
All Medicare Procedures & Services
238 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 744 | 1,168 | $402,960 | $98,510 | 24.4% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 137 | 139 | $398,930 | $95,573 | 24.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 265 | 265 | $149,809 | $40,347 | 26.9% |
| 93655 | Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | Facility | 2023 | 132 | 134 | $131,990 | $29,917 | 22.7% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 42 | 42 | $97,776 | $27,165 | 27.8% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 251 | 590 | $42,480 | $26,786 | 63.1% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 74 | 74 | $172,642 | $25,660 | 14.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 145 | 225 | $62,775 | $20,366 | 32.4% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 56 | 56 | $75,040 | $19,894 | 26.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 142 | 149 | $73,022 | $19,455 | 26.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 788 | 1,251 | $108,837 | $18,856 | 17.3% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 527 | 823 | $66,663 | $17,584 | 26.4% |
| 33225 | Insertion of left lower heart electrode for pacemaker or defibrillator | Facility | 2023 | 44 | 44 | $48,004 | $14,641 | 30.5% |
| 93653 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | Facility | 2023 | 19 | 20 | $42,780 | $11,868 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 99 | 99 | $44,451 | $11,666 | 26.2% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 272 | 436 | $70,196 | $11,043 | 15.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 76 | 80 | $35,024 | $10,152 | 29.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 345 | 392 | $37,422 | $9,456 | 25.3% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 276 | 507 | $38,025 | $9,272 | 24.4% |
| 93657 | Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | Facility | 2023 | 37 | 38 | $37,544 | $8,494 | 22.6% |
| 93650 | Destruction of heart conduction tissue to create heart block | Facility | 2023 | 22 | 22 | $33,000 | $8,267 | 25.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 540 | 745 | $44,700 | $7,160 | 16.0% |
| 33228 | Removal and replacement of dual lead permanent pacemaker | Facility | 2023 | 26 | 26 | $22,152 | $6,715 | 30.3% |
| 33274 | Insertion of permanent leadless pacemaker using imaging guidance | Facility | 2023 | 21 | 21 | $27,321 | $6,640 | 24.3% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 113 | 135 | $20,790 | $5,677 | 27.3% |
About Dr. David Lan, MD
Dr. David Lan, MD is a Internal Medicine healthcare provider based in Germantown, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1588641526.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Lan, MD has received a total of $221,102 in payments from pharmaceutical and medical device companies, with $8,264 received in 2024. These payments were reported across 1,310 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($120,600).
As a Medicare-enrolled provider, Lan has provided services to 29,329 Medicare beneficiaries, totaling 45,297 services with total Medicare billing of $2.7M. Data is available for 4 years (2020–2023), covering 238 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Clinical Cardiac Electrophysiology
- Location Germantown, TN
- Active Since 12/30/2005
- Last Updated 03/16/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1588641526
Products in Payments
- Arctic Front (Device) $67,050
- Carto 3 (Device) $1,993
- Carto 3 System (Device) $1,836
- WATCHMAN (Device) $1,823
- GENERAL - THERAPIES (Device) $1,709
- CryoConsole (Device) $1,596
- CARTO 3 (Device) $1,331
- ENTRESTO (Drug) $1,206
- ELIQUIS (Drug) $1,149
- EVERA MRI XT DR SURESCAN (Device) $1,139
- Sotalol Hydrochloride (Drug) $1,022
- LEQVIO (Drug) $481.94
- LifeVest (Device) $394.42
- GENERAL THERAPIES (Device) $381.97
- GENERAL THERAPIES (Device) $325.87
- CHANTIX (Drug) $301.76
- JARDIANCE (Drug) $294.83
- XARELTO (Drug) $275.42
- RHYTHMIA (Device) $268.58
- FARXIGA (Drug) $251.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Germantown
Dr. Ari Vanderwalde, M.d, M.D
Internal Medicine — Payments: $48,555
Internal Medicine $48,555
Dr. John Trujillo, M.d, M.D
Internal Medicine — Payments: $28,212
Internal Medicine $28,212
Dr. Vinu Ganti, Md, MD
Internal Medicine — Payments: $20,803
Internal Medicine $20,803
Dr. Mark Goldstein, Md, MD
Internal Medicine — Payments: $20,002
Internal Medicine $20,002
James Ensor, Md, MD
Internal Medicine — Payments: $13,746
Internal Medicine $13,746
Yaser Cheema, Md, MD
Internal Medicine — Payments: $12,560
Internal Medicine $12,560